Institut du cancer de Montréal
Corporate brand
UnclaimedA Montreal cancer research institute founded in 1947 that funds and supports researchers working to find new cancer treatments.
Last updated September 16, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
The Institut du cancer de Montréal is a cancer research institute whose stated mission is to innovate in research and contribute to finding new treatments against cancer. It describes its vision as empowering today's and tomorrow's researchers of the CRCHUM Cancer axis to defeat cancer, and states affiliations with the CHUM and the Université de Montréal. Founded in 1947 by two physicians of Hôpital Notre-Dame, Dr Louis-Charles Simard and Dr Antonio Cantero, it is described as the first French-language cancer research centre in America. In 1994 the Institute and the Centre de recherche de l'Hôpital Notre-Dame joined forces to create the Centre de recherche Louis-Charles Simard. The Institute also organizes benefit events and publishes news about its researchers' discoveries, projects, prizes and events.
History
The Institut du cancer de Montréal was founded in 1947 by two physicians of Hôpital Notre-Dame, Dr Louis-Charles Simard, a pathologist, and Dr Antonio Cantero, a gastroenterologist, and is described as the first French-language cancer research centre in America. In the first years after its founding, the Institute affiliated with Hôpital Notre-Dame and the Université de Montréal to carry out its mission, while continuing to operate as an independent research institute for several decades. In 1994, the Institute and the Centre de recherche de l'Hôpital Notre-Dame joined forces to create the Centre de recherche Louis-Charles Simard, which now assumes administrative responsibility for the research teams. The Institute states that since its founding it has played a determining role in various advances in the fight against cancer and has gained recognition as a translational and clinical research centre, with the ultimate goal of translating laboratory advances into clinical protocols for cancer patients.
Products and positioning
A pioneer and a pole of excellence in cancer research in North America, recognized as a translational and clinical research centre.
Sources4 sources
Cite this profile: Cite the canonical profile. /brand-wiki/institut-du-cancer-de-montréal · Editorial policy · How profiles are compiled